A new study validates that circulating autoantibodies are the direct physiological drivers behind the chronic symptom burden in a distinct subset of long COVID patients.
A new study validates that circulating autoantibodies are the direct physiological drivers behind the chronic symptom burden in a distinct subset of long COVID patients.
Share this Article
Recommended